Glycogen Branching Enzyme Deficiency in Horses: Fatal Foal Muscle Disease
- See your vet immediately if a newborn or young foal is weak, cannot stand or nurse well, has low body temperature, collapses, or shows seizures.
- Glycogen branching enzyme deficiency, or GBED, is a fatal inherited disease in Quarter Horse–related breeds caused by a recessive GBE1 gene mutation.
- Affected foals cannot store glycogen normally in muscle, heart, and liver, so they may develop severe weakness, low blood sugar, respiratory failure, or sudden death.
- There is no curative treatment. Care focuses on confirming the diagnosis, supporting the foal, and helping the pet parent and breeding program avoid future affected foals.
- Genetic testing of breeding horses is the most effective prevention step. Carrier-to-carrier matings have a 25% risk of producing an affected foal.
What Is Glycogen Branching Enzyme Deficiency in Horses?
Glycogen branching enzyme deficiency, usually called GBED, is an inherited glycogen storage disease seen mainly in Quarter Horses and related breeds, including Paint Horses, Appaloosas, and Pony of the Americas lines. The disorder is caused by a mutation in the GBE1 gene. Foals with two copies of the mutation cannot make normal branched glycogen, which means their muscles and other tissues cannot store and use energy the way they should.
This disease is considered fatal. Some pregnancies end in abortion or stillbirth. Other foals are born alive but are weak from the start, struggle to nurse, or develop repeated episodes of collapse, low blood sugar, or breathing trouble. Sudden death can also occur. Because the heart and skeletal muscles are heavily affected, these foals often decline quickly even with supportive care.
GBED is different from many other muscle problems because it is genetic and present from conception. It is not caused by training, feeding mistakes, or infection. That matters for pet parents because the most helpful long-term step is often not treatment alone, but confirming the diagnosis and making careful breeding decisions with your vet and breeding team.
Symptoms of Glycogen Branching Enzyme Deficiency in Horses
- Weakness at birth or in the first days of life
- Difficulty standing, nursing, or keeping up with normal foal activity
- Low body temperature (hypothermia)
- Flexural limb deformities or a stiff, abnormal gait
- Intermittent collapse or profound fatigue after mild activity
- Recurrent low blood sugar episodes
- Breathing weakness or ventilatory failure
- Seizures or sudden death
- Abortion, stillbirth, or a late-term nonviable foal
See your vet immediately if a foal is weak, cold, not nursing normally, or seems mentally dull. These signs can overlap with sepsis, prematurity, neonatal maladjustment, and other emergencies, so rapid veterinary evaluation matters. GBED can look subtle at first, then worsen fast.
Some affected foals survive beyond the first day but remain unusually weak, have repeated low-energy episodes, or collapse after mild exertion. If there is any Quarter Horse–related breeding history, or a previous unexplained abortion or weak foal in the line, tell your vet right away because that history can help guide testing.
What Causes Glycogen Branching Enzyme Deficiency in Horses?
GBED is caused by an autosomal recessive mutation in the GBE1 gene. A foal must inherit one mutated copy from each parent to be affected. Horses with only one copy are called carriers. Carriers are usually healthy themselves, but they can pass the mutation to offspring.
The enzyme affected by this mutation is needed to build normal branched glycogen. Without it, the body forms abnormal glycogen and cannot store energy properly in tissues that need it most, especially skeletal muscle, heart muscle, and liver. That energy failure is why affected foals may be weak, hypoglycemic, or unable to maintain normal muscle and respiratory function.
This condition is most strongly associated with Quarter Horse bloodlines and related breeds. Carrier frequency in U.S. Quarter Horses has been reported around 8% to 11%, and Paint Horses also carry the mutation. Because two outwardly normal carriers can produce an affected foal, the disease may appear unexpectedly unless breeding horses are genetically screened in advance.
How Is Glycogen Branching Enzyme Deficiency in Horses Diagnosed?
Diagnosis starts with your vet putting together the breed history, age of onset, clinical signs, and lab work. Affected foals may have persistent leukopenia, intermittent hypoglycemia, and increased muscle enzymes such as CK and AST. These findings are not specific to GBED, but they can raise concern when paired with severe weakness in a Quarter Horse–related foal.
The most direct way to confirm the disease is genetic testing for the known GBE1 mutation. This can often be done from hair roots, blood, or tissue samples. In some cases, especially after abortion, stillbirth, or euthanasia, your vet may also recommend tissue evaluation. Special staining of muscle, heart, or liver can show abnormal glycogen storage patterns that support the diagnosis.
Because several neonatal conditions can look similar, your vet may also test for sepsis, failure of passive transfer, prematurity-related problems, neurologic disease, or other muscle disorders. That broader workup is important. It helps rule out treatable emergencies while also giving the family clear answers about prognosis and future breeding risk.
Treatment Options for Glycogen Branching Enzyme Deficiency in Horses
Spectrum of Care means you have options. Here are treatment tiers at different price points.
Budget-Conscious Care
- Urgent farm call or clinic exam
- Basic blood glucose and physical assessment
- Discussion of likely prognosis based on breed, age, and signs
- Targeted genetic sample submission if feasible
- Humane euthanasia discussion when suffering is significant
Recommended Standard Treatment
- Complete veterinary exam and neonatal assessment
- CBC, chemistry profile, muscle enzymes, and blood glucose testing
- Genetic testing for GBED
- Short-term supportive care such as warming, assisted nursing, or IV dextrose as directed by your vet
- Prognosis counseling and breeding-risk discussion for sire and dam
Advanced / Critical Care
- Referral hospital or intensive foal care
- Continuous monitoring, IV fluids, dextrose support, oxygen, and respiratory support as indicated
- Expanded infectious disease and neonatal critical care testing
- Muscle or tissue biopsy/pathology when needed
- Necropsy and tissue submission after death or euthanasia for definitive diagnosis and herd planning
Cost estimates as of 2026-03. Actual costs vary by location, clinic, and individual case.
Questions to Ask Your Vet About Glycogen Branching Enzyme Deficiency in Horses
Bring these questions to your vet appointment to get the most out of your visit.
- Do my foal's signs fit GBED, or are there other emergencies we need to rule out first?
- What tests do you recommend today, and which ones are most likely to confirm the diagnosis quickly?
- Is genetic testing available from hair, blood, or tissue samples in this case?
- What supportive care options are reasonable, and what outcomes should I realistically expect?
- How will we know if my foal is suffering and when euthanasia should be considered?
- Should the sire and dam be tested for carrier status before any future breeding?
- If this foal dies or is euthanized, would necropsy or tissue testing help confirm GBED?
- What breeding combinations should be avoided to prevent another affected foal?
How to Prevent Glycogen Branching Enzyme Deficiency in Horses
The most effective prevention is genetic testing before breeding. Because GBED is autosomal recessive, two healthy-looking carriers can produce an affected foal. If both parents are carriers, each pregnancy has a 25% chance of an affected foal, a 50% chance of a carrier foal, and a 25% chance of a foal with no copies of the variant.
For Quarter Horses and related breeds, ask your vet and breeding program whether both the mare and stallion have documented GBED test results. Avoiding carrier-to-carrier matings is the key step. A carrier horse is not necessarily unhealthy, but breeding decisions should be made carefully so affected foals are not produced.
If you have had an unexplained abortion, stillbirth, or weak newborn foal in a related bloodline, talk with your vet before the next breeding season. Reviewing records, confirming past diagnoses when possible, and testing breeding stock can protect future foals and reduce emotional and financial strain for the whole farm.